Genome analysis of coxsackievirus B1 isolates during the consecutive alternating administration course of triple antiviral combination in newborn mice

BACKGROUND: We developed a new approach for the treatment of enterovirus infections, the consecutive alternating administration (CAA) of a combination of enterovirus inhibitors. On the model of coxsackievirus B1 (CVB1) in mice, two phenomena were observed: absence of drug resistance and increased su...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antivir Chem Chemother
Autors principals: Grozdanov, Petar, Joffret, Marie-Line, Stoyanova, Adelina, Polston, Patsy, Achouri, Emna, Nikolova, Ivanka, Delpeyroux, Francis, Galabov, Angel S
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7013111/
https://ncbi.nlm.nih.gov/pubmed/32041425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040206620906061
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars